Aimovig Coupons & Prices

If you're comparing an Aimovig coupon against the manufacturer's savings card, here's what to know: Aimovig (erenumab-aooe) is a once-monthly self-injected biologic approved specifically for preventing migraine in adults, and while there's no generic version to fall back on, an Rx.com cash coupon can still help you find a lower price at a nearby pharmacy—enter your ZIP above to see today's price.

What Is Aimovig and How Does It Work?

Aimovig is the brand name for erenumab-aooe, a monoclonal antibody that blocks the CGRP (calcitonin gene-related peptide) receptor, a pathway believed to play a key role in migraine attacks. It's FDA-approved for the preventive treatment of migraine in adults—meaning it's meant to reduce how often migraines happen over time, not to stop an attack that's already started.

Aimovig comes as a 70 mg or 140 mg prefilled autoinjector or syringe, given as a single subcutaneous (under-the-skin) injection once a month. There's no loading dose; you and your provider determine the starting dose based on your needs.

Aimovig Coupon vs. the Manufacturer Savings Card

Amgen offers an official Aimovig savings program through the drug's own website (aimovig.com), but like most manufacturer copay cards, it's generally available only to people with commercial (private/employer) insurance, and terms and eligibility vary—it typically can't be used if you're uninsured, on Medicare or Medicaid, or if your insurance rejects the claim.

That's where an Rx.com cash coupon fits in. It works regardless of insurance status, so it's a useful option if you're uninsured, enrolled in Medicare, or if the manufacturer card gets declined at the pharmacy counter. There is currently no generic version of Aimovig, so a cash coupon at a participating pharmacy is one of the more direct ways to manage what you pay out of pocket—enter your ZIP above to compare pharmacy prices near you.

How Aimovig Compares to Other Migraine Prevention Options

Aimovig is one of several CGRP-targeting options for migraine prevention. Other injectable CGRP monoclonal antibodies include Ajovy (fremanezumab) and Emgality (galcanezumab), which work similarly but differ in dosing schedule and injection frequency. There are also oral CGRP-pathway medications, such as Nurtec ODT and Qulipta, for patients who prefer a pill over an injection.

Botox (onabotulinumtoxinA) is a different class of treatment entirely—injected by a provider in-office every 12 weeks for chronic migraine—and works through a different mechanism than CGRP blockers. Which option fits best depends on migraine frequency, treatment history, and personal preference, so this is a conversation to have with your prescriber.

Aimovig Safety Information

The most commonly reported side effects of Aimovig are injection-site reactions, constipation, muscle spasms or cramps, and itching. The FDA has added a warning and contraindication for hypersensitivity reactions, including rash, angioedema, and anaphylaxis—Aimovig should not be used by anyone with a serious allergic reaction to erenumab or its ingredients. In rare cases, constipation associated with Aimovig has been severe enough to require surgery.

Aimovig does not carry an FDA boxed warning. Safety in pregnancy and breastfeeding hasn't been well established due to limited data, and because CGRP has a role in blood vessel dilation, some caution is advised in people with cardiovascular risk factors, though no clear safety signal has been confirmed. This is general information, not medical advice—talk to your provider about whether Aimovig is right for you.